Impairment of in vitro natural antibacterial activity in HIV-infected patients.
Circulating PBMC of healthy subjects possess an in vitro natural antibacterial (NA) against enteropathogenic bacteria, including Salmonella species. The effector cell of NA activity is a CD: 4+, 8-, Leu-8/TQ-1+ T lymphocyte acting against bacteria via cytophylic IgA in a mechanism similar to antibody-dependent cellular activity. Because AIDS is a profound immunodeficiency caused by HIV involving primarily CD4 lymphocytes and in particular the Leu-8/TQ-1 subset, it was of interest to assess NA activity of HIV+ subjects at various stages of the disease. Results indicate that NA activity against Salmonella typhi and Salmonella paratyphi C is significantly decreased in AIDS as well as in lymphadenopathy syndrome patients. Furthermore, sera containing IgA against salmonellae were not able to arm PBMC from HIV+ patients. The humoral response against S. typhi-LPS was also greatly decreased after HIV infection, in contrast to the known hypergammaglobulinemia seen in these subjects. Defective NA activity might contribute to the increased incidence of salmonellosis observed in AIDS.
Tagliabue
A
A
Sclavo Research Center, Siena, Italy.
Nencioni
L
L
Mantovani
A
A
Lazzarin
A
A
Villa
L
L
Romano
M
M
Rossini
S
S
Foppa
C U
CU
Fanetti
G
G
Masello
L C
LC
D000386:AIDS-Related Complex / Q000276:immunology; D000163:Acquired Immunodeficiency Syndrome / Q000276:immunology*; D000898:Antibiosis; D000920:Antibody-Dependent Cell Cytotoxicity; D006801:Humans; D007111:Immunity, Cellular; D007113:Immunity, Innate; D008297:Male; D010641:Phenotype; D012307:Risk Factors; D012485:Salmonella typhi / Q000276:immunology*; D013601:T-Lymphocytes / Q000145:classification / Q000276:immunology